-
Uncategorized2 months ago
Top 10 Organoid Companies
The past year marked a proverbial inflection point for organoid models designed to uncover biological insights previously unattainable through traditional cell culture experiments or animal models....
-
Uncategorized2 months ago
Trump signs order to put 100% pharma tariffs on drugs, countries without trade deals
President Donald Trump has signed an executive order confirming that drug products that come from a subset of countries and manufacturers will face 100% tariffs within...
-
Uncategorized2 months agoSTAT+: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House
WASHINGTON — The Trump administration is negotiating new drug-pricing deals, now with smaller companies, according to three people with knowledge of the meetings, including a White...
-
Uncategorized2 months agoAccelerating Organoid Adoption Set to Transform Cancer Drugs
Since the FDA’s April 2025 announcement to phase out required animal testing in favor of human-first preclinical models for monoclonal antibody therapies and other drugs, the...
-
Uncategorized2 months ago
Aspect Biosystems gets $79M from Canadian government for diabetes cell therapy
An ambitious Vancouver startup is trying to ensure the next big diabetes breakthrough retains its ties to Canada, unlike the insulin developers of a century ago....
-
Uncategorized2 months ago
Blocking AhR Sensor Activates Regenerative Program in Injured Neurons
A molecular switch in neurons regulates the regrowth of damaged axonal fibers. This is according to findings in mice, published in a new Nature paper titled...
-
Uncategorized2 months agoSTAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
Uncategorized2 months ago
DOJ weighs in favor of pharma on 340B dispute
Pharma is gaining ground in a yearslong struggle over access to federal drug discounts. Drugmakers and the federal government have historically been on opposing sides of...
-
Uncategorized2 months agoImmunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJM
Shares of Immunovant, Alto and Oric Pharmaceuticals fell this week on clinical trial updates. Elsewhere, Orca Bio’s cell therapy hit a delay and Korsana entered a...
-
Uncategorized2 months ago
Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
A day after Eli Lilly gained FDA approval for its obesity pill Foundayo, Novo Nordisk is fighting back with an analysis that it says shows the...
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
